The online version of this article (doi:10.1186/s12933-017-0520-z) contains supplementary material, which is available to authorized users.
Ellie Paige and Katya L. Masconi contributed equally to this work
We aimed to (1) assess the association between lipoprotein(a) [Lp(a)] concentration and incident type-2 diabetes in the Bruneck study, a prospective population-based study, and (2) combine findings with evidence from published studies in a literature-based meta-analysis.
We used Cox proportional hazards models to calculate hazard ratios (HR) for incident type-2 diabetes over 20 years of follow-up in 815 participants of the Bruneck study according to their long-term average Lp(a) concentration. For the meta-analysis, we searched Medline, Embase and Web of Science for relevant prospective cohort studies published up to October 2016.
In the Bruneck study, there was a 12% higher risk of type-2 diabetes for a one standard deviation lower concentration of log Lp(a) (HR = 1.12 [95% CI 0.95–1.32]; P = 0.171), after adjustment for age, sex, alcohol consumption, body mass index, smoking status, socioeconomic status, physical activity, systolic blood pressure, HDL cholesterol, log high-sensitivity C-reactive protein and waist–hip ratio. In a meta-analysis involving four prospective cohorts with a total of 74,575 participants and 4514 incident events, the risk of type-2 diabetes was higher in the lowest two quintiles of Lp(a) concentrations (weighted mean Lp(a) = 3.3 and 7.0 mg/dL, respectively) compared to the highest quintile (62.9 mg/dL), with the highest risk of type-2 diabetes seen in quintile 1 (HR = 1.28 [1.14–1.43]; P < 0.001).
The current available evidence from prospective studies suggests that there is an inverse association between Lp(a) concentration and risk of type-2 diabetes, with a higher risk of type-2 diabetes at low Lp(a) concentrations (approximately <7 mg/dL).
Additional file 1. Online appendix.
Onat A, Can G, Ornek E, Sansoy V, Aydin M, Yuksel H. Abdominal obesity with hypertriglyceridaemia, lipoprotein(a) and apolipoprotein A-I determine marked cardiometabolic risk. Eur J Clin Invest. 2013;43(11):1129–39. PubMed
Onat A, Coban N, Can G, Yuksel M, Karagoz A, Yuksel H, Ademoglu E, Erginel-Unaltuna N. Low, “quotient” Lp(a) concentration mediates autoimmune activation and independently predicts cardiometabolic risk. Exp Clin Endocrinol Diabetes. 2015;123(1):11–8. PubMed
Principle of independent assortment. http://www.nature.com/scitable/definition/principle-of-independent-assortment-law-of-independent-302.
Willeit J, Kiechl S. Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis. A population-based study. Arterioscler Thromb Vasc Biol. 1993;13(5):661–8. CrossRef
WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications: part 1: diagnosis and classification of diabetes mellitus. Geneva: WHO; 1999.
Gavin JR, Alberti KG, Davidson MB, et al. Report of the expert committee on the diagnosis, and classification of diabetes mellitus. Diabetes Care. 1997;20(7):1183–97. CrossRef
Team RDC. R: a language and environment for statistical computing. In Computing RFfS. Vienna, Austria; 2016.
White IR. Multivariate random-effects meta-analysis. Stata J. 2009;9(1):40.
White IR. Multivariate random-effects meta-regression: updates to mvmeta. Stata J. 2011;11(2):255.
Viney NJ, van Capelleveen JC, Geary RS, Xia S, Tami JA, Yu RZ, Marcovina SM, Hughes SG, Graham MJ, Crooke RM, et al. Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials. Lancet. 2016;388(10057):2239–53. CrossRefPubMed
- Lipoprotein(a) and incident type-2 diabetes: results from the prospective Bruneck study and a meta-analysis of published literature
Katya L. Masconi
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II